|
文献名
|
提交时间
|
查询结果
|
回复时间
|
|
Phase III study of immmediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small cell lung cancer
|
2017-02-15 16:29:55
|
已发送至邮箱
|
2017-02-16 08:54:48
|
|
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small cell lung cancer previously treated with platinumcontaining chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group
|
2017-02-15 16:29:35
|
暂时未查到相关文献
|
2017-02-15 19:48:58
|
|
Intratumoral injection of lipopolysaccharide causes regression of subcutaneously implanted mouse glioblastoma multiforme
|
2017-02-15 16:29:09
|
已发送至邮箱
|
2017-02-16 08:50:20
|
|
Phase II study of weekly paclitaxel in patients with non-small cell lung cancer who have failed previous treatments
|
2017-02-15 16:28:49
|
已发送至邮箱
|
2017-02-16 08:48:11
|
|
Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer
|
2017-02-15 16:28:27
|
已发送至邮箱
|
2017-02-16 08:51:35
|
|
Single-agent versus combination chemotherapy in advanced non-small cell lung cancer: the cancer and leukemia group B (study 9730)
|
2017-02-15 16:28:04
|
已发送至邮箱
|
2017-02-15 19:43:11
|
|
Redifferentiation therapy in brain tumors: long-lasting complete regression of glioblastomas and an anaplastic astrocytoma under long term 1-alpha-hydroxycholecalciferol
|
2017-02-15 16:27:52
|
已发送至邮箱
|
2017-02-15 20:11:35
|
|
Randomized, phase III study of gemcitabine or erlotinib maintenance therapy versus observation, with predefined second-line treatment, after cisplatingemcitabine induction chemotherapy in advanced non-small celll lung cancer
|
2017-02-15 16:26:49
|
暂时未查到相关文献
|
2017-02-15 18:32:50
|
|
Phase III trial of gemcitabine plus carboplatin versus single agent gemcitabine in the treatment of locally advanced or metastatic non-small cell lung cancer: the Swedish Lung Cancer Study group
|
2017-02-15 16:26:15
|
已发送至邮箱
|
2017-02-15 17:34:22
|
|
Gemcitabine in locally advanced and metastatic non-small cell lung cancer: the Central European phase II study
|
2017-02-15 16:25:15
|
已发送至邮箱
|
2017-02-16 08:59:19
|